Search Results - "HARTMAN, NEIL"

Refine Results
  1. 1

    Prevalence of Cardiac Amyloidosis in Patients Referred for Transcatheter Aortic Valve Replacement by Scully, Paul R., Treibel, Thomas A., Fontana, Marianna, Lloyd, Guy, Mullen, Michael, Pugliese, Francesca, Hartman, Neil, Hawkins, Philip N., Menezes, Leon J., Moon, James C.

    “…Wild-type transthyretin amyloid (wtATTR) affects the heart, causing a restrictive cardiomyopathy-deposits can be found in up to 25% of individuals >85 years of…”
    Get full text
    Journal Article
  2. 2

    In vitro UGT1A1 inhibition by tyrosine kinase inhibitors and association with drug-induced hyperbilirubinemia by Qosa, Hisham, Avaritt, Brittany R., Hartman, Neil R., Volpe, Donna A.

    Published in Cancer chemotherapy and pharmacology (01-11-2018)
    “…Purpose Hyperbilirubinemia has been observed in patients treated with tyrosine kinase inhibitor (TKI) drugs. Therefore, it would be beneficial to understand…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Characterization of a commercially available line of iPSC hepatocytes as models of hepatocyte function and toxicity for regulatory purposes by Qosa, Hisham, Ribeiro, Alexandre J.S., Hartman, Neil R., Volpe, Donna A.

    “…It has recently become possible to produce hepatocytes from human induced pluripotent stem cells (iPSC-heps), which may offer some advantages over primary…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Distribution of injected technetium(99m)-labeled mesenchymal stem cells in horses with naturally occurring tendinopathy by Becerra, Patricia, Valdés Vázquez, Miguel A, Dudhia, Jayesh, Fiske-Jackson, Andrew R, Neves, Francisco, Hartman, Neil G, Smith, Roger K W

    Published in Journal of orthopaedic research (01-07-2013)
    “…This study aimed to investigate immediate cell survival and distribution following different administration routes of mesenchymal stem cells (MSCs) into…”
    Get full text
    Journal Article
  7. 7

    Human radiolabeled mass balance studies supporting the FDA approval of new drugs by Ramamoorthy, Anuradha, Bende, Girish, Chow, Edwin Chiu Yuen, Dimova, Hristina, Hartman, Neil, Jean, Daphney, Pahwa, Sonia, Ren, Yunzhao, Shukla, Chinmay, Yang, Yuching, Doddapaneni, Suresh, Danielsen, Zhixia Yan

    Published in Clinical and translational science (01-11-2022)
    “…Human radiolabeled mass balance studies are an important component of the clinical pharmacology programs supporting the development of new investigational…”
    Get full text
    Journal Article
  8. 8

    In Vivo Imaging and Tracking of Technetium-99m Labeled Bone Marrow Mesenchymal Stem Cells in Equine Tendinopathy by Dudhia, Jayesh, Becerra, Patricia, Valdés, Miguel A, Neves, Francisco, Hartman, Neil G, Smith, Roger K W

    Published in Journal of visualized experiments (09-12-2015)
    “…Recent advances in the application of bone marrow mesenchymal stem cells (BMMSC) for the treatment of tendon and ligament injuries in the horse suggest…”
    Get full text
    Journal Article
  9. 9

    More methemoglobin is produced by benzocaine treatment than lidocaine treatment in human in vitro systems by Hartman, Neil R., Mao, Jinzhe J., Zhou, Hongfei, Boyne, Michael T., Wasserman, Adam M., Taylor, Kellie, Racoosin, Judith A., Patel, Vikram, Colatsky, Thomas

    Published in Regulatory toxicology and pharmacology (01-10-2014)
    “…•Benzocaine produces extensive methemoglobin when exposed to blood and liver enzymes.•Lidocaine produces no methemoglobin under the same conditions as…”
    Get full text
    Journal Article
  10. 10

    Reaction of Geldanamycin and C17-Substituted Analogues with Glutathione:  Product Identifications and Pharmacological Implications by Cysyk, Richard L, Parker, Robert J, Barchi, Joseph J, Steeg, Patricia S, Hartman, Neil R, Strong, John M

    Published in Chemical research in toxicology (01-03-2006)
    “…17-Dimethylaminoethylamino-17-demethoxygeldanamycin (DMAG) and 17-allylamino-17-demethoxygeldanamycin (17-AAG) are two derivatives of geldanamycin (GA) that…”
    Get full text
    Journal Article
  11. 11

    Technetium-99m-Tetrofosmin as a Substrate for P-Glycoprotein: In Vitro Studies in Multidrug-Resistant Breast Tumor Cells by Ballinger, James R, Bannerman, James, Boxen, Izzie, Firby, Patricia, Hartman, Neil G, Moore, Malcolm J

    Published in The Journal of nuclear medicine (1978) (01-09-1996)
    “…The accumulation of 99mTc-tetrofosmin (TFos) was studied in wildtype (WT) and doxorubicin-resistant (AdrR) variants of the rat MatB and human MCF-7 breast…”
    Get full text
    Journal Article
  12. 12

    Stability and Comparative Metabolism of Selected Felbamate Metabolites and Postulated Fluorofelbamate Metabolites by Postmitochondrial Suspensions by Parker, Robert J, Hartman, Neil R, Roecklein, Bryan A, Mortko, Henry, Kupferberg, Harvey J, Stables, James, Strong, John M

    Published in Chemical research in toxicology (01-12-2005)
    “…Evidence has been presented suggesting that a reactive metabolite, 2-phenylpropenal (ATPAL), may be responsible for the toxicities observed during therapy with…”
    Get full text
    Journal Article
  13. 13

    Does P-glycoprotein have a role in the lung clearances of inhaled 99mTc-sestamibi and 99mTc-tetrofosmin? by Cheow, Heok K, Ruparelia, Prina, Shankar, Sonal, Szczepura, Katherine R, Ballinger, James R, Hartman, Neil G, Chilvers, Edwin R, Peters, A Michael

    Published in Nuclear medicine communications (01-08-2009)
    “…OBJECTIVEThe clearance rate of inhaled Tc-sestamibi from the lungs of healthy nonsmoking individuals is much slower than would be expected from its physical…”
    Get full text
    Journal Article
  14. 14

    Pulmonary elimination rate of inhaled 99mTc‐sestamibi radioaerosol is delayed in healthy cigarette smokers by Ruparelia, Prina, Cheow, Heok K., Evans, John W., Banney, Leith, Shankar, Sonal, Szczepura, Katherine R., Swift, Anna E., Ballinger, James R., Hartman, Neil G., Chilvers, Edwin R., Peters, A. Michael

    Published in British journal of clinical pharmacology (01-04-2008)
    “…WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Very little is known about the physiology of P‐glycoprotein (P‐gp) expression in the lungs. • Ex vivo evidence based…”
    Get full text
    Journal Article
  15. 15
  16. 16

    In situ β-irradiation of a brain arteriovenous malformation model by ROY, Daniel, SOUCY, Jean-Paul, HARTMAN, Neil G, JANICKI, Christian, WEILL, Alain, GUILBERT, Francois, PAPINEAU, Karl, RAYMOND, Jean

    Published in Stroke (1970) (01-11-2005)
    “…The treatment of large brain arteriovenous malformations (BAVMs) is challenging, and embolization alone is seldom curative. The study goal is to enhance the…”
    Get full text
    Journal Article
  17. 17

    sup.89Zr-labelled Obinutuzumab: a potential immuno-PET radiopharmaceutical by Sarcan, Elif Tugce, Paisey, Stephen, Ruthardt, Ma, Ozer, Asuman Yekta, Marshall, Christopher, Hartman, Neil

    “…Obinutuzumab (Obi) is a clinically approved a next-generation monoclonal antibody (mAb), showing specific binding to the CD20 B-cell surface markers which is a…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20